South and Central America Dermal Fillers Market Dynamics and Trends by 2028

The South and Central America dermal fillers market is expected to reach US$ 600.67 million by 2028 from US$ 295.63 million in 2021; it is estimated to grow at a CAGR of 10.7% from 2021 to 2028.

The growth of the market is attributed to the factors such as preference for minimally invasive procedures, growth in population of age 30–65 years, and rise in the attraction of consumers toward beauty and wellness. However, the high cost of surgeries hinders the South and Central America Dermal Fillers market growth.

In recent years, the adoption of minimally invasive procedures has increased worldwide. Several minimally invasive dermatological techniques have been developed for facial rejuvenation. Injectable dermal fillers can be injected through a needle into the upper layers of the dermis to treat superficial fine wrinkles or into the deep dermis or subcutaneous space for facial volume augmentation. According to the statistics from the American Society of Plastic Surgeons (ASPS), more than 2.7 million dermal filler procedures were performed in 2019. Further, Allergan stated that the unit sales of dermal filler treatments increased by 17%. Age is a significant factor governing specific needs regarding medical aesthetic procedures. People of age 35–55 prefer minimally invasive aesthetic procedures over surgery. Minimally invasive cosmetic and aesthetic procedures have now become an established interdisciplinary topic, and plastic surgeons showing greater will to explore them. The rise of nonsurgical technologies and new treatment options has made aesthetics more accessible to a broader audience. Collectively, the greater benefits and accuracy of minimally invasive procedures over traditional surgical procedures are expected to drive the market during the forecast period. The ever-increasing interest in retaining a youthful physical appearance has facilitated various minimally invasive dermatological techniques. With the ever-increasing popularity of nonsurgical enhancement and a growing number of patients who have been treated, the demand for fillers continues to rise. Also, the surging inclination among people of age of 30–65 with signs of aging, such as lack of skin elasticity, wrinkles, and dark spots, is anticipated to drive the demand for dermal fillers in the coming years.

Latin American countries are witnessing continuous rise in COVID-19 cases. Currently, countries in this region are rapidly increasing clinical programs to fight the disease, and the healthcare sectors have redirected their focus toward its management. Many dermatology clinics were shut down in 2020. Thus, the dermal fillers market in South and Central America has witnessed negative effect of the COVID-19 pandemic.

 

SOUTH AND CENTRAL AMERICA DERMAL FILLERS MARKET SEGMENTATION

By Product

• Biodegradable
• Non-Biodegradable

By Material

• Calcium Hydroxylapatite
• Hyaluronic Acid
• Collagen
• Poly-L-Lactic Acid
• Polymethylmethacrylate (PMMA)
• Fat Fillers
• Other

By Application

• Facial Line Correction Treatment
• Lip Enhancement
• Face Lift
• Scar Treatment
• Others

By End User

• Dermatology Clinics
• Multispecialty Hospitals
• Ambulatory Surgical Centers
• Others

By Country

• Brazil
• Argentina
• Rest of South and Central America

Company Profiles

• AbbVie Inc.
• Galderma
• Merz Pharma
• Suneva Medical
• HUADONG MEDICINE CO., LTD
• Prollenium Medical Technologies

South and Central America Dermal Fillers Report Scope